These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


184 related items for PubMed ID: 24200063

  • 21. [Relationships between the expressions of intercellular adhesion molecule-1 and tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9 in lung tissues of patients with chronic obstructive pulmonary disease].
    Kong YJ, Sun WX, Zhang YM, Shi YZ.
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 Feb; 31(2):129-33. PubMed ID: 18683786
    [Abstract] [Full Text] [Related]

  • 22. [Effect of HMGB1-siRNA on proliferation and apoptosis of HepG2 cells].
    He XC, Fan XG, Liu HB, Zhou RR, Wang HC.
    Zhonghua Gan Zang Bing Za Zhi; 2010 May; 18(5):361-5. PubMed ID: 20510002
    [Abstract] [Full Text] [Related]

  • 23. Dibutyryl cyclic AMP-induced enhancement of tissue inhibitor of metalloproteinases-3 expression and its possible relation to the invasive activity of the human hepatoma cell line PLC/PRF/5.
    Okamoto Y, Nakano H.
    Anticancer Res; 1999 May; 19(6B):5175-80. PubMed ID: 10697530
    [Abstract] [Full Text] [Related]

  • 24. [Inhibitory effects of RNA interference on expression of matrix metalloproteinase-9 gene and invasiveness and adhesion in ovarian cancer cells].
    Hu XX, Li L, Li DR, Zhang W, Tang BJ.
    Zhonghua Fu Chan Ke Za Zhi; 2006 Sep; 41(9):579-83. PubMed ID: 17181964
    [Abstract] [Full Text] [Related]

  • 25. Calpains are required for invasive and metastatic potentials of human HCC cells.
    Chen B, Tang J, Guo YS, Li Y, Chen ZN, Jiang JL.
    Cell Biol Int; 2013 Jul; 37(7):643-52. PubMed ID: 23733271
    [Abstract] [Full Text] [Related]

  • 26. [Expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in the hepatocellular carcinomas].
    Wei QY, Wu YQ, Fan SQ.
    Hunan Yi Ke Da Xue Xue Bao; 2003 Jun; 28(3):212-6. PubMed ID: 14653069
    [Abstract] [Full Text] [Related]

  • 27. (-)-Epigallocatechin-3-gallate down-regulates EGFR, MMP-2, MMP-9 and EMMPRIN and inhibits the invasion of MCF-7 tamoxifen-resistant cells.
    Farabegoli F, Papi A, Orlandi M.
    Biosci Rep; 2011 Apr; 31(2):99-108. PubMed ID: 20446926
    [Abstract] [Full Text] [Related]

  • 28. Dihydromyricetin inhibits migration and invasion of hepatoma cells through regulation of MMP-9 expression.
    Zhang QY, Li R, Zeng GF, Liu B, Liu J, Shu Y, Liu ZK, Qiu ZD, Wang DJ, Miao HL, Li MY, Zhu RZ.
    World J Gastroenterol; 2014 Aug 07; 20(29):10082-93. PubMed ID: 25110435
    [Abstract] [Full Text] [Related]

  • 29. Expression of matrix metalloproteinase-2 and -9 and their inhibitors, tissue inhibitor of metalloproteinase-1 and -2, in primary cultures of human prostatic stromal and epithelial cells.
    Wilson MJ, Sellers RG, Wiehr C, Melamud O, Pei D, Peehl DM.
    J Cell Physiol; 2002 May 07; 191(2):208-16. PubMed ID: 12064464
    [Abstract] [Full Text] [Related]

  • 30. Reduced high-mobility group box 1 expression induced by RNA interference inhibits the bioactivity of hepatocellular carcinoma cell line HCCLM3.
    Jiang W, Wang Z, Li X, Li J, Huang Y, Fan X, Duan Y.
    Dig Dis Sci; 2012 Jan 07; 57(1):92-8. PubMed ID: 22038506
    [Abstract] [Full Text] [Related]

  • 31. EFEMP1 inhibits migration of hepatocellular carcinoma by regulating MMP2 and MMP9 via ERK1/2 activity.
    Dou CY, Cao CJ, Wang Z, Zhang RH, Huang LL, Lian JY, Xie WL, Wang LT.
    Oncol Rep; 2016 Jun 07; 35(6):3489-95. PubMed ID: 27108677
    [Abstract] [Full Text] [Related]

  • 32. [Effect of epigallocatechin-3-gallate on the invasiveness of hepatocarcinoma cells in vitro].
    Lu L, Liu HM, Tang WX.
    Zhonghua Gan Zang Bing Za Zhi; 2007 Nov 07; 15(11):825-7. PubMed ID: 18357659
    [Abstract] [Full Text] [Related]

  • 33. Suppression of plasminogen activators and the MMP-2/-9 pathway by a Zanthoxylum avicennae extract to inhibit the HA22T human hepatocellular carcinoma cell migration and invasion effects in vitro and in vivo via phosphatase 2A activation.
    Dung TD, Feng CC, Kuo WW, Pai P, Chung LC, Chang SH, Hsu HH, Tsai FJ, Lin YM, Huang CY.
    Biosci Biotechnol Biochem; 2013 Nov 07; 77(9):1814-21. PubMed ID: 24018669
    [Abstract] [Full Text] [Related]

  • 34. [Abnormal expression of APRIL in colorectal cancer cells promotes tumor growth and metastasis].
    Wang GH, Lu MH, Wang JC, Wang F, Ding WF, Wang YG, Ju SQ, Wang HM.
    Zhonghua Zhong Liu Za Zhi; 2013 Apr 07; 35(4):249-55. PubMed ID: 23985251
    [Abstract] [Full Text] [Related]

  • 35. Lowered HGK expression inhibits cell invasion and adhesion in hepatocellular carcinoma cell line HepG2.
    Han SX, Zhu Q, Ma JL, Zhao J, Huang C, Jia X, Zhang D.
    World J Gastroenterol; 2010 Sep 28; 16(36):4541-8. PubMed ID: 20857524
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Inhibitory effects of a benz[f]indole-4,9-dione analog on cancer cell metastasis mediated by the down-regulation of matrix metalloproteinase expression in human HT1080 fibrosarcoma cells.
    Park HJ, Lee HJ, Min HY, Chung HJ, Suh ME, Park-Choo HY, Kim C, Kim HJ, Seo EK, Lee SK.
    Eur J Pharmacol; 2005 Dec 19; 527(1-3):31-6. PubMed ID: 16309669
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 10.